MENU
PTGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Protagonist Therapeutics (PTGX) Earnings Date & Reports
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
PTGX is expected to report earnings to fall 4.37% to $2.19 per share on November 05
Q3'26
Est.
$2.19
Q2'26
Beat
by $0.16
Q1'26
Beat
by $0.54
Q4'25
Missed
by $0.35
Q3'25
Beat
by $0.01
The last earnings report on August 05 showed earnings per share of $2.29, beating the estimate of $2.13. With 619.95K shares outstanding, the current market capitalization sits at 8.93B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of disulfide-rich peptides
Industry Biotechnology
Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
132
Web
https://www.protagonist-inc.com